Enliven Therapeutics, Inc.ELVNNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-6.91%
↑ 43% above average
Average (7y)
-12.06%
Historical baseline
Range
High:-2.32%
Low:-31.97%
CAGR
+10.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -6.91% | +44.6% |
| 2023 | -12.48% | +61.0% |
| 2022 | -31.97% | -16.4% |
| 2021 | -27.48% | -1083.7% |
| 2020 | -2.32% | +72.7% |
| 2019 | -8.49% | -150.8% |
| 2018 | -3.39% | +0.1% |
| 2017 | -3.39% | - |